Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | DPP4 | P27487 | 1/20 | 0.50 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.50 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | CDK9 | P50750 | 1/20 | 0.47 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7072835 | 1.00 | HPGD (0.56) | HPGDMAPTGAAPOLBMEN1 | |
| SCHEMBL7069083 | 0.95 | HPGD (0.51) | HPGDMAPTGAAPOLBMEN1 | |
| SCHEMBL7069093 | 0.95 | HPGD (0.51) | HPGDMAPTGAAPOLBMEN1 | |
| SCHEMBL2392383 | 0.91 | HPGD (0.56) | HPGDMAPTGAAPOLBMEN1 | |
| SCHEMBL9352214 | 0.91 | HPGD (0.56) | HPGDMAPTGAAPOLBMEN1 | |
| SCHEMBL2172641 | 0.91 | HPGD (0.56) | HPGDMAPTGAAPOLBMEN1 | |
| SCHEMBL516052 | 0.90 | HPGD (0.58) | HPGDMAPTGAAPOLBMEN1 | |
| SCHEMBL13708499 | 0.90 | HPGD (0.58) | HPGDMAPTGAAPOLBMEN1 | |
| Hydrochloric Acid SCHEMBL4306381 | 0.90 | SCN3A (0.56) | HPGDMAPTGAAPOLBMEN1 | |
| Hydrochloric Acid SCHEMBL3266984 | 0.89 | HPGD (0.57) | HPGDMAPTGAAPOLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030120088-A1 | Optically active azetidincarboxamide-coordinated transition metal complexes | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-06-26 | — | — | US | disclosed |
| EP-1319660-A1 | Optically active azetidincarboxamide-coordinated transition metal complexes as catalysts in asymmetric reduction | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030120088-A1 | Optically active azetidincarboxamide-coordinated transition metal complexes | AAAS, AP1M1, AP2A1 | HPGD 4448/4885MAPT 4413/4885GAA 2464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.